BreezeBio is a biotechnology company developing precision genetic medicines enabled by targeted, non-viral delivery across biologically relevant tissues. Using our proprietary NanoGalaxy® platform, we engineer nanoparticles designed to deliver genetic payloads, including mRNA, to specific cell types. Our platform has demonstrated delivery to immune cells as well as select tissues in the heart, lung, and central nervous system. We are advancing an internal therapeutic pipeline focused on autoimmune diseases and oncology. Our lead program, BRZ-101, is designed to restore immune tolerance in type 1 diabetes and is advancing into IND-enabling studies. BreezeBio is headquartered in the South San Francisco area.

BreezeBio

Kunwoo Lee

This department focuses on scientific research and the development of innovative products and solutions.

Research and Development

This department is responsible for defining and guiding the overall strategic direction and business objectives of the organization.

Corporate Strategy

This department oversees the planning, execution, and delivery of projects to ensure they meet organizational goals and requirements.

Program Management

This department provides expert guidance and strategic insights to support decision-making and organizational growth.

Advisory Services

This department focuses on the overall strategic direction and operational leadership of the organization.

Executive Management

This department conducts studies and analyses to advance knowledge and support innovation.

BreezeBio

Org chart

Teams

Research and Development

Corporate Strategy

Program Management

Advisory Services

Executive Management

Research Department

Offices

BreezeBio

Org chart

Teams

Research and Development

Corporate Strategy

Program Management

Advisory Services

Executive Management

Research Department

Offices

Related companies